Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|P10s-PADRE||P10s-PADRE is a peptide vaccine comprised of a carbohydrate mimetic-peptide (P10s) and a pan-T-cell epitope (PADRE), which mimics the ganglioside G2 and LeY antigens, thereby potentially inducing the production of antibodies and leading to reduced cell viability and increased apoptosis (PMID: 29228761, PMID: 32582547).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT02229084||Phase Ib/II||Montanide ISA 51 + P10s-PADRE P10s-PADRE||Vaccination of High Risk Breast Cancer Patients||Recruiting||USA||0|